Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2016 2018

Augmented immune targeting of a myeloma-specific tumour antigen.

Shortt, J., Spencer, A., Reynolds, J., Johnstone, R. W., Quach, H., Grigoriadis, G., Kalff, A., Khong, T. T. F., Walker, P. & Powell, D. R.

15/12/1631/12/18

Project: Research

Research Output 1999 2017

Circulating tumour DNA analysis demonstrates spatial mutational heterogeneity that coincides with disease relapse in myeloma

Mithraprabhu, S., Khong, T., Ramachandran, M., Chow, A., Klarica, D., Mai, L., Walsh, S., Broemeling, D., Marziali, A., Wiggin, M., Hocking, J., Kalff, A., Durie, B. & Spencer, A. 1 Aug 2017 In : Leukemia. 31, 8, p. 1695-1705 11 p.

Research output: Contribution to journalArticle

A rare case of IGH/MYC and IGH/BCL2 double hit primary plasma cell leukemia

Kalff, A., Khong, T., Wall, M., Gorniak, M., Mithraprabhu, S., Campbell, L. J. & Spencer, A. 2015 In : Haematologica: the hematology journal. 100, 2, p. e60-e62 3 p.

Research output: Contribution to journalLetter

Open Access

MDX-1097 induces antibody-dependent cellular cytotoxicity against kappa multiple myeloma cells and its activity is augmented by lenalidomide

Asvadi, P., Cuddihy, A. R., Dunn, R., Jiang, V., Wong, M. X., Jones, D. R., Khong, T. T. F. & Spencer, A. 2015 In : British Journal of Haematology. 169, 3, p. 333 - 343 11 p.

Research output: Contribution to journalArticle

TOP2A knockdown resensitizes carfilzomib-resistant Hmcls to carfilzomib

Reale, A., Khong, T. T., Mithraprabhu, S., Savvidou, I., Ramachandran, M. & Spencer, A. Dec 2015 p. 4215 1 p.

Research output: Contribution to conferenceAbstract

Dysregulated Class I histone deacetylases are indicators of poor prognosis in multiple myeloma

Mithraprabhu, S., Kalff, A., Chow, A., Khong, T. T. F. & Spencer, A. 2014 In : Epigenetics. 9, 11, p. 1511 - 1520 10 p.

Research output: Contribution to journalArticle